Intervention in autoimmunity: The potential of vitamin D receptor agonists

Cellular Immunology

Volumn 233, Issue 2, 2005, Pages 115-124

  Adorini, Luciano ^a  

^a BioXell SpA   (Italy)

Author keywords

Autoimmune diseases; Immunomodulation; Tolerogenic dendritic cells; Vitamin D analogs

Indexed keywords

1,25 DIHYDROXY 16,23 DIENE 26,27 HEXAFLUORO 19 NORCOLECALCIFEROL; 20 EPICALCITRIOL; CALCITRIOL; CD4 ANTIGEN; COLECALCIFEROL DERIVATIVE; CYCLOSPORIN A; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INTERLEUKIN 2 RECEPTOR ALPHA; UNCLASSIFIED DRUG; VITAMIN D RECEPTOR;

ALLERGIC ENCEPHALOMYELITIS; ANTIGEN PRESENTING CELL; AUTOIMMUNE DISEASE; AUTOIMMUNITY; CELL FUNCTION; CELL TYPE; CONFERENCE PAPER; DENDRITIC CELL; DOWN REGULATION; ENTERITIS; HUMAN; IMMUNOREGULATION; IN VITRO STUDY; IN VIVO STUDY; INSULIN DEPENDENT DIABETES MELLITUS; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; PSORIASIS; RHEUMATOID ARTHRITIS; SIGNAL TRANSDUCTION; SUPPRESSOR CELL; SYSTEMIC LUPUS ERYTHEMATOSUS; T LYMPHOCYTE; TH1 CELL;

ADJUVANTS, IMMUNOLOGIC; ANIMALS; AUTOIMMUNE DISEASES; DISEASE MODELS, ANIMAL; HUMANS; RECEPTORS, CALCITRIOL;

EID: 23044479095     PISSN: 00088749     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.cellimm.2005.04.013     Document Type: Conference Paper

References (110)

1. L. Adorini Selective immunointervention in autoimmune diseases: lessons from multiple sclerosis J. Chemother. 13 2001 219 234
2. P.T. Coates, B.L. Colvin, K. Kaneko, T. Taner, and A.W. Thomson Pharmacologic, biologic, and genetic engineering approaches to potentiation of donor-derived dendritic cell tolerogenicity Transplantation 75 2003 32S 36S
3. L. Adorini, N. Giarratana, and G. Penna Pharmacological induction of tolerogenic dendritic cells and regulatory T cells Semin. Immunol. 16 2004 127 134
4. H.F. Deluca, and M.T. Cantorna Vitamin D: its role and uses in immunology FASEB J. 15 2001 2579 2585
5. C. Mathieu, and L. Adorini The coming of age of 1,25-dihydroxyvitamin D(3) analogs as immunomodulatory agents Trends Mol. Med. 8 2002 174 179
6. M.D. Griffin, N. Xing, and R. Kumar Vitamin D and its analogs as regulators of immune activation and antigen presentation Annu. Rev. Nutr. 2003
7. K.V. Pinette, Y.K. Yee, B.Y. Amegadzie, and S. Nagpal Vitamin D receptor as a drug discovery target Mini. Rev. Med. Chem. 3 2003 193 204
8. A.W. Norman, M.T. Mizwicki, and W.H. Okamura Ligand structure-function relationships in the vitamin D endocrine system from the perspective of drug development (including cancer treatment) Recent Results Cancer Res. 164 2003 55 82
9. M.R. Haussler, G.K. Whitfield, C.A. Haussler, J.C. Hsieh, P.D. Thompson, S.H. Selznick, C.E. Dominguez, and P.W. Jurutka The nuclear vitamin D receptor: biological and molecular regulatory properties revealed J. Bone Miner. Res. 13 1998 325 349
10. A.W. Norman, S. Ishizuka, and W.H. Okamura Ligands for the vitamin D endocrine system: different shapes function as agonists and antagonists for genomic and rapid response receptors or as a ligand for the plasma vitamin D binding protein J. Steroid Biochem. Mol. Biol. 76 2001 49 59
11. C. Carlberg, and P. Polly Gene regulation by vitamin D3 Crit. Rev. Eukaryot. Gene Expr. 8 1998 19 42
12. A.K. Bhalla, E.P. Amento, B. Serog, and L.H. Glimcher 1,25-Dihydroxyvitamin D3 inhibits antigen-induced T cell activation J. Immunol. 133 1984 1748 1754
13. J.M. Lemire, D.C. Archer, L. Beck, and H.L. Spiegelberg Immunosuppressive actions of 1,25-dihydroxyvitamin D3: preferential inhibition of Th1 functions J. Nutr. 125 1995 1704S 1708S
14. 3 Eur. J. Immunol. 30 2000 498 508
15. 3: direct inhibition NFATp/AP-1 complex formation by a nuclear hormone receptor Mol. Cell. Biol. 15 1995 5789 5799
16. 3-mediated effects J. Immunol. 160 1998 209 218
17. M. Cippitelli, and A. Santoni Vitamin D3: a transcriptional modulator of the interferon-gamma gene Eur. J. Immunol. 28 1998 3017 3030
18. + T cells to enhance the development of Th2 cells J. Immunol. 167 2001 4974 4980
19. G. Penna, and L. Adorini 1,25-Dihydroxyvitamin D3 inhibits differentiation, maturation, activation and survival of dendritic cells leading to impaired alloreactive T cell activation J. Immunol. 164 2000 2405 2411
20. L. Piemonti, P. Monti, M. Sironi, P. Fraticelli, B.E. Leone, E. Dal Cin, P. Allavena, and V. Di Carlo Vitamin D3 affects differentiation, maturation, and function of human monocyte-derived dendritic cells J. Immunol. 164 2000 4443 4451
21. M.D. Griffin, W.H. Lutz, V.A. Phan, L.A. Bachman, D.J. McKean, and R. Kumar Potent inhibition of dendritic cell differentiation and maturation by vitamin D analogs Biochem. Biophys. Res. Commun. 270 2000 701 708
22. A. Berer, J. Stockl, O. Majdic, T. Wagner, M. Kollars, K. Lechner, K. Geissler, and L. Oehler 1,25-Dihydroxyvitamin D(3) inhibits dendritic cell differentiation and maturation in vitro Exp. Hematol. 28 2000 575 583
23. M.O. Canning, K. Grotenhuis, H. de Wit, C. Ruwhof, and H.A. Drexhage 1-alpha,25-Dihydroxyvitamin D3 (1,25(OH)(2)D(3)) hampers the maturation of fully active immature dendritic cells from monocytes Eur. J. Endocrinol. 145 2001 351 357
24. A.G. van Halteren, E. van Etten, E.C. de Jong, R. Bouillon, B.O. Roep, and C. Mathieu Redirection of human autoreactive T-cells upon interaction with dendritic cells modulated by TX527, an analog of 1,25 dihydroxyvitamin D(3) Diabetes 51 2002 2119 2125
25. L. Adorini Immunomodulatory effects of vitamin D receptor ligands in autoimmune diseases Int. Immunopharmacol. 2 2002 1017 1028
26. P.F. Barnes, R.L. Modlin, D.D. Bikle, and J.S. Adams Transpleural gradient of 1,25-dihydroxyvitamin D in tuberculous pleuritis J. Clin. Invest. 83 1989 1527 1532
27. J. Cadranel, M. Garabedian, B. Milleron, H. Guillozo, G. Akoun, and A.J. Hance 1,25(OH)2D2 production by T lymphocytes and alveolar macrophages recovered by lavage from normocalcemic patients with tuberculosis J. Clin. Invest. 85 1990 1588 1593
28. L. Overbergh, B. Decallonne, D. Valckx, A. Verstuyf, J. Depovere, J. Laureys, O. Rutgeerts, R. Saint-Arnaud, R. Bouillon, and C. Mathieu Identification and immune regulation of 25-hydroxyvitamin D-1-alpha-hydroxylase in murine macrophages Clin. Exp. Immunol. 120 2000 139 146
29. M. Hewison, L. Freeman, S.V. Hughes, K.N. Evans, R. Bland, A.G. Eliopoulos, M.D. Kilby, P.A. Moss, and R. Chakraverty Differential regulation of vitamin D receptor and its ligand in human monocyte-derived dendritic cells J. Immunol. 170 2003 5382 5390
30. M.D. Griffin, W. Lutz, V.A. Phan, L.A. Bachman, D.J. McKean, and R. Kumar Dendritic cell modulation by 1alpha,25 dihydroxyvitamin D3 and its analogs: a vitamin D receptor-dependent pathway that promotes a persistent state of immaturity in vitro and in vivo Proc. Natl. Acad. Sci. USA 98 2001 6800 6805
31. T. Koizumi, Y. Nakao, T. Matsui, T. Nakagawa, S. Matsuda, K. Komoriya, Y. Kanai, and T. Fujita Effects of corticosteroid and 1,24R-dihydroxy-vitamin D3 administration on lymphoproliferation and autoimmune disease in MRL/MP-lpr/lpr mice Int. Arch. Allergy Appl. Immunol. 77 1985 396 404
32. J. Abe, K. Nakamura, Y. Takita, T. Nakano, H. Irie, and Y. Nishii Prevention of immunological disorders in MRL/l mice by a new synthetic analogue of vitamin D3: 22-oxa-1 alpha,25-dihydroxyvitamin D3 J. Nutr. Sci. Vitaminol. (Tokyo) 36 1990 21 31
33. J.M. Lemire, A. Ince, and M. Takashima 1,25-Dihydroxyvitamin D3 attenuates the expression of experimental murine lupus of MRL/l mice Autoimmunity 12 1992 143 148
34. J.M. Lemire, and D.C. Archer 1,25-Dihydroxyvitamin D3 prevents the in vivo induction of murine experimental autoimmune encephalomyelitis J. Clin. Invest. 87 1991 1103 1107
35. M.T. Cantorna, C.E. Hayes, and H.F. DeLuca 1,25-Dihydroxyvitamin D3 reversibly blocks the progression of relapsing encephalomyelitis, a model of multiple sclerosis Proc. Natl. Acad. Sci. USA 93 1996 7861 7864
36. P. Larsson, L. Mattsson, L. Klareskog, and C. Johnsson A vitamin D analogue (MC 1288) has immunomodulatory properties and suppresses collagen-induced arthritis (CIA) without causing hypercalcaemia Clin. Exp. Immunol. 114 1998 277 283
37. M.T. Cantorna, C.E. Hayes, and H.F. DeLuca 1,25-Dihydroxycholecalciferol inhibits the progression of arthritis in murine models of human arthritis J. Nutr. 128 1998 68 72
38. M.T. Cantorna, C. Munsick, C. Bemiss, and B.D. Mahon 1,25- Dihydroxycholecalciferol prevents and ameliorates symptoms of experimental murine inflammatory bowel disease J. Nutr. 130 2000 2648 2652
39. C. Mathieu, M. Waer, J. Laureys, O. Rutgeerts, and R. Bouillon Prevention of autoimmune diabetes in NOD mice by 1,25 dihydroxyvitamin D3 Diabetologia 37 1994 552 558
40. C. Mathieu, M. Waer, K. Casteels, J. Laureys, and R. Bouillon Prevention of type I diabetes in NOD mice by nonhypercalcemic doses of a new structural analog of 1,25-dihydroxyvitamin D3, KH1060 Endocrinology 136 1995 866 872
41. 3 analog enhances regulatory T cells and arrests autoimmune diabetes in NOD mice Diabetes 51 2002 1374 1376
42. K. Casteels, M. Waer, J. Laureys, D. Valckx, J. Depovere, R. Bouillon, and C. Mathieu Prevention of autoimmune destruction of syngeneic islet grafts in spontaneously diabetic nonobese diabetic mice by a combination of a vitamin D3 analog and cyclosporine Transplantation 65 1998 1225 1232
43. 3 and mycophenolate mofetil treatment mediate transplantation tolerance J. Immunol. 167 2001 1945 1953
44. K.M. Casteels, C. Mathieu, M. Waer, D. Valckx, L. Overbergh, J.M. Laureys, and R. Bouillon Prevention of type I diabetes in nonobese diabetic mice by late intervention with nonhypercalcemic analogs of 1,25-dihydroxyvitamin D3 in combination with a short induction course of cyclosporin A Endocrinology 139 1998 95 102
45. E. van Etten, D.D. Branisteanu, A. Verstuyf, M. Waer, R. Bouillon, and C. Mathieu Analogs of 1,25-dihydroxyvitamin D3 as dose-reducing agents for classical immunosuppressants Transplantation 69 2000 1932 1942
46. H. Schulze-Koops, and J.R. Kalden The balance of Th1/Th2 cytokines in rheumatoid arthritis Best Pract. Res. Clin. Rheumatol. 15 2001 677 691
47. L.C. Tetlow, and D.E. Woolley Expression of vitamin D receptors and matrix metalloproteinases in osteoarthritic cartilage and human articular chondrocytes in vitro Osteoarthritis Cartilage 9 2001 423 431
48. L.C. Tetlow, and D.E. Woolley The effects of 1 alpha,25-dihydroxyvitamin D(3) on matrix metalloproteinase and prostaglandin E(2) production by cells of the rheumatoid lesion Arthritis Res. 1 1999 63 70
49. M.A. Atkinson, and E.H. Leiter The NOD mouse model of type 1 diabetes: as good as it gets? Nat. Med. 5 1999 601 604
50. C. Benoist, and D. Mathis Cell death mediators in autoimmune diabetes-no shortage of suspects Cell 89 1997 1 3
51. S. Trembleau, G. Penna, E. Bosi, A. Mortara, M.K. Gately, and L. Adorini IL-12 administration induces Th1 cells and accelerates autoimmune diabetes in NOD mice J. Exp. Med. 181 1995 817 821
52. W.M. Ridgway, M. Fasso, A. Lanctot, C. Garvey, and C.G. Fathman Breaking self-tolerance in nonobese diabetic mice J. Exp. Med. 183 1996 1657 1662
53. T.L. Delovitch, and B. Singh The non-obese diabetic mouse as a model of autoimmune diabetes: immune dysregulation gets the NOD Immunity 7 1997 727 738
54. L. Adorini Interleukin 12 and autoimmune diabetes Nat. Genet. 27 2001 131 132
55. B. Salomon, D.J. Lenschow, L. Rhee, N. Ashourian, B. Singh, A. Sharpe, and J.A. Bluestone B7/CD28 costimulation is essential for the homeostasis of the CD4+CD25+ immunoregulatory T cells that control autoimmune diabetes Immunity 12 2000 431 440
56. C. Mathieu, J. Laureys, H. Sobis, M. Vandeputte, M. Waer, and R. Bouillon 1,25-Dihydroxyvitamin D3 prevents insulitis in NOD mice Diabetes 41 1992 1491 1495
57. C. Mathieu, K. Casteels, R. Boullion, Vitamin D and Diabetes, Academic Press, New York, 1997.
58. M.R. Uskokovic, A.W. Norman, P.S. Manchand, G.P. Studzinski, M.J. Campbell, H.P. Koeffler, A. Takeuchi, M. Siu-Caldera, D.S. Rao, and G.S. Reddy Highly active analogs of 1alpha,25-dihydroxyvitamin D(3) that resist metabolism through C-24 oxidation and C-3 epimerization pathways Steroids 66 2001 463 471
59. H. Jonuleit, E. Schmitt, G. Schuler, J. Knop, and A.H. Enk Induction of interleukin 10-producing, nonproliferating CD4(+) T cells with regulatory properties by repetitive stimulation with allogeneic immature human dendritic cells J. Exp. Med. 192 2000 1213 1222
60. K.M. Casteels, C.A. Gysemans, M. Waer, R. Bouillon, J.M. Laureys, J. Depovere, and C. Mathieu Sex difference in resistance to dexamethasone-induced apoptosis in NOD mice: treatment with 1,25(OH)2D3 restores defect Diabetes 47 1998 1033 1037
61. K.M. Spach, L.B. Pedersen, F.E. Nashold, T. Kayo, B.S. Yandell, T.A. Prolla, and C.E. Hayes Gene expression analysis suggests that 1,25-dihydroxyvitamin D3 reverses experimental autoimmune encephalomyelitis by stimulating inflammatory cell apoptosis Physiol. Genomics 18 2004 141 151
62. L. Adorini, S. Gregori, and L.C. Harrison Understanding autoimmune diabetes: insights from mouse models Trends Mol. Med. 8 2002 31 38
63. N. Giarratana, G. Penna, S. Amuchastegui, R. Mariani, K.C. Daniel, and L. Adorini A vitamin D analog downregulates proinflammatory chemokine production by pancreatic islets inhibiting T cell recruitment and type 1 diabetes development J. Immunol. 173 2004 2280 2287
64. D. Rossi, and A. Zlotnik The biology of chemokines and their receptors Annu. Rev. Immunol. 18 2000 217 242
65. A. Shimada, J. Morimoto, K. Kodama, R. Suzuki, Y. Oikawa, O. Funae, A. Kasuga, T. Saruta, and S. Narumi Elevated serum IP-10 levels observed in type 1 diabetes Diabetes Care 24 2001 510 515
66. F. Nicoletti, I. Conget, M. Di Mauro, R. Di Marco, M.C. Mazzarino, K. Bendtzen, A. Messina, and R. Gomis Serum concentrations of the interferon-gamma-inducible chemokine IP-10/CXCL10 are augmented in both newly diagnosed Type I diabetes mellitus patients and subjects at risk of developing the disease Diabetologia 45 2002 1107 1110
67. L. Piemonti, B.E. Leone, R. Nano, A. Saccani, P. Monti, P. Maffi, G. Bianchi, A. Sica, G. Peri, R. Melzi, L. Aldrighetti, A. Secchi, V. Di Carlo, P. Allavena, and F. Bertuzzi Human pancreatic islets produce and secrete MCP-1/CCL2: relevance in human islet transplantation Diabetes 51 2002 55 65
68. J.H. Xie, N. Nomura, M. Lu, S.L. Chen, G.E. Koch, Y. Weng, R. Rosa, J. Di Salvo, J. Mudgett, L.B. Peterson, L.S. Wicker, and J.A. DeMartino Antibody-mediated blockade of the CXCR3 chemokine receptor results in diminished recruitment of T helper 1 cells into sites of inflammation J. Leukoc. Biol. 73 2003 771 780
69. S. Frigerio, T. Junt, B. Lu, C. Gerard, U. Zumsteg, G.A. Hollander, and L. Piali Beta cells are responsible for CXCR3-mediated T-cell infiltration in insulitis Nat. Med. 8 2002 1414 1420
70. A.G. Uitterlinden, Y. Fang, J.B. Van Meurs, H.A. Pols, and J.P. Van Leeuwen Genetics and biology of vitamin D receptor polymorphisms Gene 338 2004 143 156
71. A. Green, E.A. Gale, and C.C. Patterson Incidence of childhood-onset insulin-dependent diabetes mellitus: the EURODIAB ACE Study Lancet 339 1992 905 909
72. Vitamin D supplement in early childhood and risk for Type I (insulin-dependent) diabetes mellitus. The EURODIAB Substudy 2 Study Group, Diabetologia 42 (1999) 51-54.
73. E. Hypponen, E. Laara, A. Reunanen, M.R. Jarvelin, and S.M. Virtanen Intake of vitamin D and risk of type 1 diabetes: a birth-cohort study Lancet 358 2001 1500 1503
74. 3 J. Neuroimmunol. 61 1995 151 160
75. 3 is a positive regulator for the two anti-encephalitogenic cytokines TGF-b1 and IL-4 J. Immunol. 160 1998 5314 5319
76. M. Racke, S. Dhib-Jalbut, B. Cannella, P. Alert, C. Raine, and D. McFarlin Prevention and treatment of chronic relapsing experimental allergic encephalomyelitis by transforming growth factor-b1 J. Immunol. 146 1991 3012 3019
77. M.K. Racke, A. Bonomo, D.E. Scott, B. Cannella, A. Levine, C.S. Raine, E.M. Shevach, and M. Roecken Cytokine-induced immune deviation as a therapy for inflammatory autoimmune disease J. Exp. Med. 180 1994 1961 1966
78. R. Furlan, P.L. Poliani, F. Galbiati, A. Bergami, L. Grimaldi, G. Comi, L. Adorini, and G. Martino Central nervous system delivery of interleukin 4 by a nonreplicative herpes simplex type 1 viral vector ameliorates autoimmune demyelination Hum. Gene Ther. 9 1998 2605 2617
79. E. Bettelli, M. Prabhu Das, E.D. Howard, H.L. Weiner, R.A. Sobel, and V.K. Kuchroo IL-10 is critical in the regulation of autoimmune encephalomyelitis as demonstrated by studies of IL-10- and IL-4-deficient and transgenic mice J. Immunol. 161 1998 3299 3306
80. F.J. Barrat, D.J. Cua, A. Boonstra, D.F. Richards, C. Crain, H.F. Savelkoul, R. de Waal-Malefyt, R.L. Coffman, C.M. Hawrylowicz, and A. O'Garra In vitro generation of interleukin 10-producing regulatory CD4(+) T cells is induced by immunosuppressive drugs and inhibited by T helper type 1 (Th1)- and Th2-inducing cytokines J. Exp. Med. 195 2002 603 616
81. 3H]1,25- dihydroxyvitamin D3 uptake by canine and rodent brain Am. J. Physiol. 244 1983 266 271
82. F. Aloisi, F. Ria, and L. Adorini Regulation of T-cell responses by CNS antigen-presenting cells: different roles for microglia and astrocytes Immunol. Today 21 2000 141 147
83. E. Garcion, S. Nataf, A. Berod, F. Darcy, and P. Brachet 1,25-Dihydroxyvitamin D3 inhibits the expression of inducible nitric oxide synthase in rat central nervous system during experimental allergic encephalomyelitis Brain Res. 45 1997 255 267
84. J.D. Simmons, C. Mullighan, K.I. Welsh, and D.P. Jewell Vitamin D receptor gene polymorphism: association with Crohn's disease susceptibility Gut 47 2000 211 214
85. B.A. Hendrickson, R. Gokhale, and J.H. Cho Clinical aspects and pathophysiology of inflammatory bowel disease Clin. Microbiol. Rev. 15 2002 79 94
86. M.T. Cantorna Vitamin D and autoimmunity: is vitamin D status an environmental factor affecting autoimmune disease prevalence? Proc. Soc. Exp. Biol. Med. 223 2000 230 233
87. C.E. Hayes Vitamin D: a natural inhibitor of multiple sclerosis Proc. Nutr. Soc. 59 2000 531 535
88. S. Bregenholt, and M.H. Claesson Increased intracellular Th1 cytokines in scid mice with inflammatory bowel disease Eur. J. Immunol. 28 1998 379 389
89. M. Niessner, and B.A. Volk Altered Th1/Th2 cytokine profiles in the intestinal mucosa of patients with inflammatory bowel disease as assessed by quantitative reversed transcribed polymerase chain reaction (RT-PCR Clin. Exp. Immunol. 101 1995 428 435
90. R. Kuhn, J. Lohler, D. Rennick, K. Rajewsky, and W. Muller Interleukin-10-deficient mice develop chronic enterocolitis Cell 75 1993 263 274
91. M. Froicu, V. Weaver, T.A. Wynn, M.A. McDowell, J.E. Welsh, and M.T. Cantorna A crucial role for the vitamin D receptor in experimental inflammatory bowel diseases Mol. Endocrinol. 17 2003 2386 2392
92. K. Asadullah, W. Sterry, and H.D. Volk Interleukin-10 therapy-review of a new approach Pharmacol. Rev. 55 2003 241 269
93. M.G. Thomas, K.P. Nugent, A. Forbes, and R.C. Williamson Calcipotriol inhibits rectal epithelial cell proliferation in ulcerative proctocolitis Gut 35 1994 1718 1720
94. M. Stio, A.G. Bonanomi, G. d'Albasio, and C. Treves Suppressive effect of 1,25-dihydroxyvitamin D3 and its analogues EB 1089 and KH 1060 on T lymphocyte proliferation in active ulcerative colitis Biochem. Pharmacol. 61 2001 365 371
95. M. Linker-Israeli, E. Elstner, J.R. Klinenberg, D.J. Wallace, and H.P. Koeffler Vitamin D(3) and its synthetic analogs inhibit the spontaneous in vitro immunoglobulin production by SLE-derived PBMC Clin. Immunol. 99 2001 82 93
96. M.W. Vaisberg, R. Kaneno, M.F. Franco, and N.F. Mendes Influence of cholecalciferol (vitamin D3) on the course of experimental systemic lupus erythematosus in F1 (NZBxW) mice. J. Clin. Lab. Anal. 14 2000 91 96
97. M.T. Cantorna, J. Humpal-Winter, and H.F. DeLuca Dietary calcium is a major factor in 1,25-dihydroxycholecalciferol suppression of experimental autoimmune encephalomyelitis in mice J. Nutr. 129 1999 1966 1971
98. K. Uyemura, M. Yamamura, D.F. Fivenson, R.L. Modlin, and B.J. Nickoloff The cytokine network in lesional and lesion-free psoriatic skin is characterized by a T-helper type 1 cell-mediated response J. Invest. Dermatol. 101 1993 701 705
99. D.M. Ashcroft, A.L. Po, H.C. Williams, and C.E. Griffiths Systematic review of comparative efficacy and tolerability of calcipotriol in treating chronic plaque psoriasis BMJ 320 2000 963 967
100. M. Barna, J.D. Bos, M.L. Kapsenberg, and F.G. Snijdewint Effect of calcitriol on the production of T-cell-derived cytokines in psoriasis Br. J. Dermatol. 136 1997 536 5341
101. S. Kang, S. Yi, C.E. Griffiths, L. Fancher, T.A. Hamilton, and J.H. Choi Calcipotriene-induced improvement in psoriasis is associated with reduced interleukin-8 and increased interleukin-10 levels within lesions Br. J. Dermatol. 138 1998 77 83
102. M. Komine, Y. Watabe, S. Shimaoka, F. Sato, K. Kake, H. Nishina, M. Ohtsuki, H. Nakagawa, and K. Tamaki The action of a novel vitamin D3 analogue, OCT, on immunomodulatory function of keratinocytes and lymphocytes Arch. Dermatol. Res. 291 1999 500 506
103. T.N. Dam, S. Kang, B.J. Nickoloff, and J.J. Voorhees 1alpha,25- Dihydroxycholecalciferol and cyclosporine suppress induction and promote resolution of psoriasis in human skin grafts transplanted on to SCID mice J. Invest. Dermatol. 113 1999 1082 1089
104. Y. Fukuya, M. Higaki, Y. Higaki, and M. Kawashima Effect of vitamin D3 on the increased expression of Bcl-xL in psoriasis Arch. Dermatol. Res. 293 2002 620 625
105. T.P. Staeva-Vieira, and L.P. Freedman 1,25-Dihydroxyvitamin D3 inhibits IFN-gamma and IL-4 levels during in vitro polarization of primary murine CD4+ T cells J. Immunol. 168 2002 1181 1189
106. L. Overbergh, B. Decallonne, M. Waer, O. Rutgeerts, D. Valckx, K.M. Casteels, J. Laureys, R. Bouillon, and C. Mathieu 1alpha,25-Dihydroxyvitamin D3 induces an autoantigen-specific T-helper 1/T-helper 2 immune shift in NOD mice immunized with GAD65 (p524-543) Diabetes 49 2000 1301 1307
107. F.E. Nashold, K.A. Hoag, J. Goverman, and C.E. Hayes Rag-1-dependent cells are necessary for 1,25-dihydroxyvitamin D3 prevention of experimental autoimmune encephalomyelitis J. Neuroimmunol. 119 2001 16 29
108. M. Cippitelli, C. Fionda, D. Di Bona, F. Di Rosa, A. Lupo, M. Piccoli, L. Frati, and A. Santoni Negative regulation of CD95 ligand gene expression by vitamin D3 in T lymphocytes J. Immunol. 168 2002 1154 1166
109. M. Vulcano, S. Struyf, P. Scapini, M. Cassatella, S. Bernasconi, R. Bonecchi, A. Calleri, G. Penna, L. Adorini, W. Luini, A. Mantovani, J. Van Damme, and S. Sozzani Unique regulation of CCL18 production by maturing dendritic cells J. Immunol. 170 2003 3843 3849
110. M. Inaba, Y. Nishizawa, K. Song, H. Tanishita, S. Okuno, T. Miki, and H. Morii Partial protection of 1 alpha-hydroxyvitamin D3 against the development of diabetes induced by multiple low-dose streptozotocin injection in CD-1 mice Metabolism 41 1992 631 635